Clinical trial
Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative…
NCT00141778 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00141778 |
|---|---|
| Title | Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF) |
| Official title | RAAS, Inflammation, and Post-operative AF |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Placebo, Ramipril, Spironolactone |
| Enrollment | 455 |
| Start date | Apr 1, 2005 |
| Primary completion | Jul 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Sep 1, 2005 |
| Last update posted | Mar 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: